Recombinant E-cadherin XY91651RPMu01

参考价:¥768
供货周期: 现货
品牌: 信裕生物
规格: 10ug/50ug/200ug/1mg
货号: XY91651RPMu01
CAS号:
上海信裕生物科技有限公司
银牌会员11年生产商
关注展位 全部试剂
产品详情

Recombinant E-cadherin

上皮性钙黏附蛋白重组蛋白

[ PROPERTIES ]

Source: Prokaryotic expression

Host: E.coli

Residues: Arg153~Phe264

Tags: N-terminal His Tag

Subcellular Location: Membrane, Golgi apparatus, Extracellular matrix

Purity: > 97%

Traits: Freeze-dried powder

Buffer formulation: PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.

Original Concentration: 200µg/mL

Applications: Positive Control; Immunogen; SDS-PAGE; WB.

(May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 5.95

Predicted Molecular Mass: 14.3kDa

Accurate Molecular Mass: 17kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles.

Store at 2-8ºC for one month.

Aliquot and store at -80ºC for 12 months.

Stability Test: The thermal stability is described by the loss rate. The loss rate was determined

by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no

obvious degradation and precipitation were observed. The loss rate is less than 5% within the

expiration date under appropriate storage condition.

[SEQUENCE ]

[  IDENTIFICATION  ]


[ IMPORTANT NOTE ]

The kit is designed for research use only, we will not be responsible for any issue if the kit was used in clinical diagnostic or any other procedures.

特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!以实际收货产品说明书为准,网站说明书仅供参考!

Recombinant E-cadherin XY91651RPMu01信息由上海信裕生物科技有限公司为您提供,如您想了解更多关于Recombinant E-cadherin XY91651RPMu01报价、型号、参数等信息, 欢迎来电或留言咨询。除供应Recombinant E-cadherin XY91651RPMu01外,上海信裕生物科技有限公司还可为您提供OVA Conjugated Chemokine (C-X-C Motif) Ligand 1 (CXCL1) XY90934CPSRa21、人抗酿酒酵母抗体(ASCA)ELISA试剂盒 等产品, 公司有专业的客户服务团队,是您值得信赖的合作伙伴。

相关试剂 更多

相关产品

当前位置: 仪器信息网 上海信裕 试剂 Recombinant E-cadherin XY91651RPMu01

关注

拨打电话

留言咨询